AMAG Profile
AMAG Pharmaceuticals, Inc. (AMAG) was a biopharmaceutical company that focused on the development and commercialization of therapies for various medical conditions. However, as of January 2021, the company has been acquired by Covis Group, a privately-held specialty pharmaceutical company.
Prior to the acquisition, AMAG's portfolio included several products addressing a range of medical needs such as iron deficiency anemia, preterm birth prevention, and intravenous magnesium sulfate therapy for the management of seizures in pregnant women with preeclampsia. The company was also involved in the development of novel treatments for cancer, gastrointestinal disorders, and other conditions.
AMAG was headquartered in Waltham, Massachusetts, and employed approximately 400 people. However, following the acquisition, the company's operations have been integrated into Covis Group.
|